DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Bilcare Limited (BI) share price today?

Bilcare Limited (BI) is trading at ₹92.51 on the NSE, down 0.49% on the day. Source: DocStoX.

What is the PE ratio of Bilcare Limited?

Bilcare Limited has a price-to-earnings (PE) ratio of 126.7 in the Healthcare sector.

What is the market capitalisation of Bilcare Limited?

Bilcare Limited has a market capitalisation of approximately ₹215 crore.

Is Bilcare Limited a profitable company?

Bilcare Limited generates a return on equity of 1.7% with a net profit margin of -2.3%. That is a modest return on shareholder capital.

What is the 52-week high and low of BI?

Bilcare Limited (BI) has traded between ₹51.62 and ₹113 over the past 52 weeks, against a current price of ₹92.51.

Bilcare Limited

₹92.51▼ -0.46 (-0.49%)

BI·NSE·Healthcare

Market Cap

214.59 Cr

PE Ratio

126.73

Volume

2,217

Day High - Low

92.51 - 91.55

52W High-Low

113.00 - 51.62

₹92.51▼ -0.46 (-0.49%)

Market Cap214.59 Cr

PE Ratio126.73

Volume2,217

Day High - Low92.51 - 91.55

52W High-Low113.00 - 51.62

Bilcare Limited (BI): company summary

The company's business is showing mixed signals, with annual revenue declining by -6.9% to ₹734 crore, while the net profit loss narrowed from ₹56 crore to ₹17 crore.

Bilcare Limited (BI) is a micro-cap Healthcare company valued at ₹215 crore operating in Healthcare Research, Analytics & Technology on the NSE and BSE.

Recent price move: Bilcare Limited last traded at ₹92.51, modestly down 0.49% on the day.
Recent developments: On 2026-06-30, the company reported a net profit of ₹15 crore for the latest quarter, marking a significant improvement from the net loss of ₹10 crore in the same quarter a year earlier. The company also reported a net loss of ₹17 crore for the latest fiscal year, which is an improvement compared to the prior year's loss of ₹56 crore.
Financial performance: The company's business is showing mixed signals, with annual revenue declining by -6.9% to ₹734 crore, while the net profit loss narrowed from ₹56 crore to ₹17 crore. The latest quarter saw revenue rise 21.5% to ₹226 crore, and the net profit swung from a loss of ₹10 crore to a profit of ₹15 crore, indicating a potential turnaround in the quarter.
Valuation multiples: The stock trades at 126.7 times earnings, a premium to the Healthcare median of 32.0, 0.73 times book value.
Things to watch: The company reported a net loss of ₹17 crore in its latest financial year, which is still a concern. The net profit margin remains negative at -2.3%, although it has improved from -7.1% in the prior year. The company also has a high debt to equity ratio of 3.15, which is a risk factor.
Where it stands: Bilcare Ltd. reported a net loss of ₹17 crore for the latest financial year, but the net profit margin improved by 4.8 percentage points to -2.3%. The latest quarter saw a significant improvement, with the company reporting a profit of ₹15 crore, up from a loss of ₹10 crore in the same quarter a year earlier. The company's debt to equity ratio is a concern at 3.15.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

1.8/10

Poor

Fair Value

ROE

1.66%

Weak

P/E

126.73x

Expensive

Debt / Equity

0.03

Low

Industry

Healthcare

Healthcare Research, Analytics & Technology

Overall View

Poor

Price performance

Day₹91.55

₹92.51

52W₹51.62

₹113.00

DocStoX take

Supported by momentum (7.4), but held back by growth (0.5).

DocStoX score

Low confidence

1.8

/10

Poor

Quality

Weak

ROE 1.7%

Valuation

Rich

P/E 126.7×

Growth

Flat

Revenue +3.3% 5Y CAGR

Risk

Elevated

D/E 0.03

Momentum

Firm

67% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹93

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹215 Cr

52W High / Low

₹113 / ₹52

Dividend Yield

0.00%

Promoter Holding

30.01%

EPS (TTM)

₹0.73

Book Value

₹83.60

Key highlights

Low leverage — D/E 0.03
Profit shrinking 86% a year
Loss-making in some of the last 5 years

1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Research, Analytics & Technology

Explore Bilcare Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Bilcare Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Bilcare Limited with peers

Bilcare Limited vs Sun Pharmaceutical Industries Limited Bilcare Limited vs Divi's Laboratories Limited Bilcare Limited vs Torrent Pharmaceuticals Limited Bilcare Limited vs Apollo Hospitals Enterprise Limited Bilcare Limited vs Zydus Lifesciences Limited Bilcare Limited vs Laurus Labs Limited

Related tools & concepts

Value Bilcare Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

BI newsLatest coverage & filings Open screenerFilter the whole market